AOD-9604 + CJC-1295 + Ipamorelin (12mg Blend Vial) Dosage Protocol Lipolytic hGH fragment (AOD-9604) + GHRH analog (CJC-1295) + GH secretagogue (Ipamorelin) in one 12 mg blend research-only, not FDA-approved
Not fun
A medical provider will typically evaluate: Starting weight and BMI Individuals with higher BMI levels may benefit from treatments that support greater appetite regulation
This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for consumption, self-experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
Pan LL, Sun Y, Dong X, Ren Z, Li B, Yang P, Zhang L, Sun J
Benefits of AOD-9604 Supports fat metabolism (lipolysis up, lipogenesis down) Stimulates bone differentiation and mineralization Promotes myoblast differentiation Supports stem-celldriven tissue repair (bone, muscle, cartilage)